(MELE) Melexis - BR
Sector: Technology | Industry: Semiconductors | Exchange: BR (Belgium) | Market Cap: 3.190m EUR | Total Return: 27.6% in 12m
Avg Turnover: 5.45M
EPS Trend: -92.3%
Qual. Beats: 0
Rev. Trend: -74.3%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Melexis NV is a Belgian semiconductor company specializing in the design and marketing of advanced integrated circuits, predominantly serving the global automotive sector. Its product portfolio includes magnetic and optical sensors, pressure and temperature monitors, and communication transceivers such as LIN and CAN components. The firm operates a fabless business model, focusing internal resources on research, design, and testing while outsourcing the capital-intensive wafer fabrication process to third-party foundries.
The company is strategically positioned to benefit from the increasing electronic content per vehicle, driven by trends in electrification and autonomous driving features. In the automotive semiconductor industry, high barriers to entry exist due to stringent safety certifications and long product lifecycles that often span over a decade. For a deeper look into the companys valuation metrics and historical performance, ValueRay provides comprehensive analytical tools. Melexis maintains a significant international presence with operations extending across Europe, the Asia Pacific, and the Americas.
- Automotive semiconductor demand slows as global electric vehicle adoption cools
- Inventory corrections at Tier-1 suppliers compress short-term revenue growth
- High R&D investment in sensor innovation maintains premium operating margins
- Expansion into non-automotive robotics and medical segments diversifies revenue base
| Net Income: 111.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.20 > 0.02 and ΔFCF/TA 5.68 > 1.0 |
| NWC/Revenue: 52.20% < 20% (prev 45.01%; Δ 7.18% < -1%) |
| CFO/TA 0.24 > 3% & CFO 201.7m > Net Income 111.0m |
| Net Debt (221.5m) to EBITDA (205.2m): 1.08 < 3 |
| Current Ratio: 5.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.5m) vs 12m ago -1.99% < -2% |
| Gross Margin: 39.00% > 18% (prev 41.64%; Δ -2.64% > 0.5%) |
| Asset Turnover: 96.07% > 50% (prev 98.27%; Δ -2.21% > 0%) |
| Interest Coverage Ratio: 15.71 > 6 (EBIT TTM 151.6m / Interest Expense TTM 9.65m) |
| A: 0.52 (Total Current Assets 547.3m - Total Current Liabilities 107.1m) / Total Assets 851.2m |
| B: 0.66 (Retained Earnings 562.7m / Total Assets 851.2m) |
| C: 0.17 (EBIT TTM 151.6m / Avg Total Assets 878.0m) |
| D: 1.42 (Book Value of Equity 499.1m / Total Liabilities 352.0m) |
| Altman-Z'' = 8.20 = AAA |
| DSRI: 1.05 (Receivables 116.1m/116.3m, Revenue 843.5m/889.2m) |
| GMI: 1.07 (GM 41.64% / 39.00%) |
| AQI: 0.59 (AQ_t 0.12 / AQ_t-1 0.20) |
| SGI: 0.95 (Revenue 843.5m / 889.2m) |
| TATA: -0.11 (NI 111.0m - CFO 201.7m) / TA 851.2m) |
| Beneish M = -3.21 (Cap -4..+1) = AA |
As of June 15, 2026, the stock is trading at EUR 80.60 with a total of 33,567 shares traded.
Over the past week, the price has changed by +0.12%,
over one month by +3.04%,
over three months by +55.42% and
over the past year by +27.61%.
Melexis has no consensus analysts rating.
P/E Trailing = 29.562
P/E Forward = 25.974
P/S = 3.7815
P/B = 6.402
P/EG = 2.5163
Revenue TTM = 843.5m EUR
EBIT TTM = 151.6m EUR
EBITDA TTM = 205.2m EUR
Long Term Debt = 233.5m EUR (from longTermDebt, last quarter)
Short Term Debt = 12.2m EUR (from shortTermDebt, last quarter)
Debt = 258.6m EUR (from shortLongTermDebtTotal, last quarter) + Leases 7.21m
Net Debt = 221.5m EUR (calculated: Debt 258.6m - CCE 37.1m)
Enterprise Value = 3.41b EUR (3.19b + Debt 258.6m - CCE 37.1m)
Interest Coverage Ratio = 15.71 (Ebit TTM 151.6m / Interest Expense TTM 9.65m)
EV/FCF = 20.34x (Enterprise Value 3.41b / FCF TTM 167.7m)
FCF Yield = 4.92% (FCF TTM 167.7m / Enterprise Value 3.41b)
FCF Margin = 19.89% (FCF TTM 167.7m / Revenue TTM 843.5m)
Net Margin = 13.16% (Net Income TTM 111.0m / Revenue TTM 843.5m)
Gross Margin = 39.00% ((Revenue TTM 843.5m - Cost of Revenue TTM 514.5m) / Revenue TTM)
Gross Margin QoQ = 39.89% (prev 38.37%)
Tobins Q-Ratio = 4.01 (Enterprise Value 3.41b / Total Assets 851.2m)
Interest Expense / Debt = 3.73% (Interest Expense 9.65m / Debt 258.6m)
Taxrate = 18.53% (25.2m / 136.2m)
NOPAT = 123.5m (EBIT 151.6m * (1 - 18.53%))
Current Ratio = 5.11 (Total Current Assets 547.3m / Total Current Liabilities 107.1m)
Debt / Equity = 0.52 (Debt 258.6m / totalStockholderEquity, last quarter 499.1m)
Debt / EBITDA = 1.08 (Net Debt 221.5m / EBITDA 205.2m)
Debt / FCF = 1.32 (Net Debt 221.5m / FCF TTM 167.7m)
Total Stockholder Equity = 506.7m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.64% (Net Income 111.0m / Total Assets 851.2m)
RoE = 21.91% (Net Income TTM 111.0m / Total Stockholder Equity 506.7m)
RoCE = 20.48% (EBIT 151.6m / Capital Employed (Equity 506.7m + L.T.Debt 233.5m))
RoIC = 17.17% (NOPAT 123.5m / Invested Capital 719.2m)
WACC = 8.77% (E(3.19b)/V(3.45b) * Re(9.24%) + D(258.6m)/V(3.45b) * Rd(3.73%) * (1-Tc(0.19)))
Discount Rate = 9.24% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -67.42 | Cagr: -1.01%
[DCF] Terminal Value 76.61% ; FCFF base≈151.4m ; Y1≈173.6m ; Y5≈255.4m
[DCF] Fair Price = 85.21 (EV 3.58b - Net Debt 221.5m = Equity 3.36b / Shares 39.4m; r=8.77% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: -92.33 | EPS CAGR: -25.03% | SUE: -0.41 | # QB: 0
Revenue Correlation: -74.30 | Revenue CAGR: -5.40% | SUE: 0.48 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.74 | Chg30d=-3.60% | Revisions=-33% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.85 | Chg30d=-1.56% | Revisions=-33% | Analysts=3
EPS current Year (2026-12-31): EPS=2.99 | Chg30d=-1.65% | Revisions=-11% | GrowthEPS=+7.5% | GrowthRev=+1.6%
EPS next Year (2027-12-31): EPS=3.80 | Chg30d=-0.02% | Revisions=+40% | GrowthEPS=+27.3% | GrowthRev=+9.6%
[Analyst] Revisions Ratio: +40%